OvaScience, Inc. (OVAS)

Recent filings

OvaScience, Inc.'s Chief Development Officer was just granted 80,000 options - May 27, 2020

OvaScience, Inc.'s Chief Financial Officer was just granted 80,000 options - May 27, 2020

OvaScience, Inc.'s Chief Medical Officer was just granted 80,000 options - May 27, 2020

OvaScience, Inc.'s President and CEO was just granted 282,000 options - May 27, 2020

OvaScience, Inc.'s General Counsel and Secretary was just granted 80,000 options - May 27, 2020

OvaScience, Inc. Just Filed Its Quarterly Report: Net loss per shareBa... - May 8, 2020

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 24, 2020

OvaScience, Inc. releases salary data. CEO sees compensation fall -1% - April 24, 2020

Nathan Every just provided an update on share ownership of OvaScience, Inc. - April 8, 2020

OvaScience: Millendo Therapeutics Announces Topline Results For Pivotal Phase 2B Study Of Livoletide In Patients With Prader-Willi Syndrome (Pws) - April 6, 2020

OvaScience, Inc.'s Chief Development Officer was just granted 15,000 options - March 31, 2020

Statement of acquisition of beneficial ownership by individuals - March 17, 2020

OvaScience, Inc. Just Filed Its Annual Report: Net loss per shareBa... - March 11, 2020

Entry into a Material Definitive - March 4, 2020

OvaScience, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 4, 2020

OvaScience, Inc.'s Chief Medical Officer just declared ownership of no shares of OvaScience, Inc. - Feb. 11, 2020

OvaScience, Inc.'s Chief Medical Officer was just granted 140,000 options - Feb. 11, 2020

OvaScience: Millendo Therapeutics Appoints Christophe Arbet-Engels, Md, Phd, As Chief Medical Officer - Feb. 10, 2020

OvaScience, Inc.'s General Counsel and Secretary was just granted 56,250 options - Feb. 4, 2020

OvaScience, Inc.'s Chief Financial Officer was just granted 71,250 options - Feb. 4, 2020

OvaScience, Inc.'s Chief Development Officer was just granted 41,250 options - Feb. 4, 2020

OvaScience, Inc.'s President and CEO was just granted 215,000 options - Feb. 4, 2020

Results of Operations and Financial - Jan. 13, 2020

OvaScience, Inc. director was just granted 24,000 options - Dec. 19, 2019

OvaScience: Geoff Nichol Appointed To Millendo Therapeutics Board Of Directors - Dec. 19, 2019

OvaScience, Inc. director just declared ownership of no shares of OvaScience, Inc. - Dec. 19, 2019

Bpifrance S.A. just provided an update on activist position in OvaScience, Inc. - Dec. 16, 2019

Securities to be offered to employees in employee benefit plans - Dec. 16, 2019

OvaScience, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 5, 2019

OvaScience: Millendo Therapeutics Announces Proposed Public Offering Of Common Stock - Dec. 5, 2019

OvaScience, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 4, 2019

OvaScience, Inc. Just Filed Its Quarterly Report: Net loss per shar... - Nov. 13, 2019

OvaScience, Inc.'s General Counsel and Secretary just declared ownership of no shares of OvaScience, Inc. - Aug. 20, 2019

OvaScience, Inc.'s Chief Development Officer just declared 107,569 options - Aug. 20, 2019

OvaScience, Inc.'s General Counsel and Secretary was just granted 130,000 options - Aug. 20, 2019

OvaScience, Inc.'s Chief Development Officer was just granted 10,000 options - Aug. 20, 2019

OvaScience, Inc. Just Filed Its Quarterly Report: Net loss per shar... - Aug. 12, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc.'s President and CEO was just granted 76,007 options - June 21, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc. director was just granted 12,000 options - June 21, 2019

OvaScience, Inc.'s Chief Financial Officer was just granted 25,000 options - June 21, 2019

OvaScience: Millendo Therapeutics Announces Departure Of Chief Medical Officer - June 18, 2019

Departure of Directors or Certain - June 13, 2019

OvaScience, Inc. Just Filed Its Quarterly Report: Net loss per shar... - May 15, 2019

OvaScience, Inc. releases salary data. CEO sees compensation rise 306% - April 29, 2019

OvaScience: Soliciting Material Under ยง240.14A-12 MILLENDO THERAPEUTICS, INC. - April 29, 2019

OvaScience, Inc. Just Received a Notice of Effectiveness - April 18, 2019

Entry into a Material Definitive - April 17, 2019

Securities to be offered to employees in employee benefit plans - April 5, 2019

Registration statement under Securities Act of 1933 - April 5, 2019

OvaScience, Inc. Just Filed Its Annual Report: Net loss per shar... - April 1, 2019

OvaScience: Millendo Reports Full Year 2018 Operating And Financial Results - March 29, 2019

OvaScience: Presentation To Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019 - March 22, 2019

Orin Hirschman just provided an update on share ownership of OvaScience, Inc. - Feb. 15, 2019

W. Lawrence Hawkins just provided an update on share ownership of OvaScience, Inc. - Feb. 14, 2019

Great Point Partners, LLC just provided an update on share ownership of OvaScience, Inc. - Feb. 14, 2019

Statement of acquisition of beneficial ownership by individuals - Feb. 7, 2019

Entry into a Material Definitive - Feb. 7, 2019

BML Investment Partners, L.P. just provided an update on share ownership of OvaScience, Inc. - Feb. 6, 2019

Jennison Associates LLCS.S. or just issued a filing suggesting it has sold all of its OvaScience, Inc. - Feb. 1, 2019

OvaScience: Millendo Therapeutics Reports Inducement Grants - Jan. 22, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

OvaScience, Inc.'s Chief Financial Officer was just granted 50,000 options - Jan. 17, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

Sec. of OvaScience, Inc. was just granted 56,000 options - Jan. 17, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

OvaScience, Inc.'s Chief Medical Officer was just granted 64,000 options - Jan. 17, 2019

OvaScience, Inc.'s President and CEO was just granted 173,993 options - Jan. 17, 2019

OvaScience, Inc. director was just granted 6,000 options - Jan. 17, 2019

OvaScience: Presentation To Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019 - Jan. 7, 2019

OvaScience, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - Dec. 20, 2018

Peter W. Sonsini just provided an update on activist position in OvaScience, Inc. - Dec. 18, 2018

Nathan Every just provided an update on share ownership of OvaScience, Inc. - Dec. 17, 2018

SHAM Innovation Sante SAS just provided an update on share ownership of OvaScience, Inc. - Dec. 17, 2018

Roche Finance Ltd just provided an update on share ownership of OvaScience, Inc. - Dec. 17, 2018

Great Point Partners, LLC just provided an update on share ownership of OvaScience, Inc. - Dec. 17, 2018

Bpifrance S.A. just provided an update on activist position in OvaScience, Inc. - Dec. 13, 2018

OvaScience: Millendo Therapeutics Announces Successful Merger Completion - Dec. 13, 2018

OvaScience, Inc.'s President and CEO just declared ownership of no shares of OvaScience, Inc. - Dec. 11, 2018

OvaScience, Inc. director just picked up 755 shares - Dec. 11, 2018

Senior Vice President of OvaScience, Inc. was just granted 5,000 options - Dec. 11, 2018

OvaScience, Inc. director just picked up 31,933 shares - Dec. 11, 2018

OvaScience, Inc. director just picked up 355 shares - Dec. 11, 2018

OvaScience, Inc.'s Chief Medical Officer just picked up 7,440 shares - Dec. 11, 2018

OvaScience, Inc. director just declared ownership of no shares of OvaScience, Inc. - Dec. 11, 2018

OvaScience, Inc.'s Chief Scientific Officer was just granted 8,333 options - Dec. 11, 2018

OvaScience, Inc.'s Chief Executive Officer was just granted 47,666 options - Dec. 11, 2018

OvaScience, Inc. director just picked up 15,784 shares - Dec. 11, 2018

OvaScience, Inc. director just picked up 831 shares - Dec. 11, 2018

OvaScience, Inc. director was just granted 21,229 options - Dec. 11, 2018

OvaScience, Inc. director was just granted 18,600 options - Dec. 11, 2018

OvaScience, Inc.'s President and CEO just picked up 74,400 shares - Dec. 11, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Longwood Fund GP, LLC 2,820,607 N/A Dec. 31, 2014
2. ORBIS HOLDINGS LTD 2,090,530 0.1 Dec. 31, 2015
3. Orbis Investment Management Limited 2,081,545 N/A Dec. 31, 2015
4. Michelle Dipp, M.D., Ph.D. 2,070,875 N/A May 13, 2016
5. Richard Aldrich 1,502,020 N/A May 13, 2016
6. Michelle Dipp, M.D., Ph.D. 1,436,964 N/A Oct. 9, 2015
7. BlackRock Fund Advisors 1,349,336 N/A Sept. 30, 2016
8. BlackRock Institutional Trust Company, N.A. 686,949 N/A Dec. 31, 2016
9. DEUTSCHE BANK AG\ 517,693 N/A Dec. 31, 2017
10. MORGAN STANLEY 155,969 N/A Dec. 31, 2016
11. BlackRock Investment Management, LLC 130,528 N/A Dec. 31, 2016
12. MARXE AUSTIN W & GREENHOUSE DAVID M 79,669 N/A Sept. 30, 2014
13. KCG Holdings, Inc. 75,011 N/A June 30, 2017
14. NORTHERN TRUST CORP 68,525 N/A March 31, 2018
15. WELLS FARGO & COMPANY/MN 55,344 N/A Sept. 30, 2018
16. BlackRock Advisors LLC 17,001 N/A Sept. 30, 2016
17. BlackRock Group LTD 8,717 N/A Sept. 30, 2016
18. BlackRock Inc. 6,392 N/A Sept. 30, 2016
19. CITIGROUP INC 5,627 N/A Sept. 30, 2017
20. MetLife Securities, Inc 2,000 N/A Dec. 31, 2016
21. BANK OF AMERICA CORP /DE/ 1,065 N/A Sept. 30, 2017
22. BANK OF MONTREAL /CAN/ 908 N/A March 31, 2018
23. ROYAL BANK OF CANADA 294 N/A Sept. 30, 2016
24. BNP PARIBAS ARBITRAGE, SA 23 N/A June 30, 2019

OvaScience, Inc. (OVAS)

140
 


Feedback